About Banyan Pacific Capital
Banyan Pacific Capital is a company based in Shenzhen (China) founded in 2015. It operates as a Commission-Based. Banyan Pacific Capital offers products and services including Technology Investments and Life Sciences Investments.
- Headquarter Shenzhen, China
-
Sectors
Financial ServicesTechnology Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Banyan Pacific Capital
Banyan Pacific Capital offers a comprehensive portfolio of products and services, including Technology Investments and Life Sciences Investments.
Investments in AI, big data, and SaaS are managed.
Investments in innovative drugs and medical devices are supported.
Funding Insights of Banyan Pacific Capital
Detailed funding history for Banyan Pacific Capital
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Banyan Pacific Capital
Investment portfolio details for Banyan Pacific Capital
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Banyan Pacific Capital
Detailed financials for Banyan Pacific Capital
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Banyan Pacific Capital Comparisons
Peer comparison for Banyan Pacific Capital
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Banyan Pacific Capital
Detailed competitors of Banyan Pacific Capital
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Banyan Pacific Capital
Complete news archive for Banyan Pacific Capital
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Banyan Pacific Capital
Banyan Pacific Capital was founded in 2015.
Banyan Pacific Capital is headquartered in Shenzhen, China. It is registered at Shenzhen, Guangdong, China.
Banyan Pacific Capital, established in 2015, is engaged in technology and life sciences investments with a focus on international expansion. Investments are made through a fund-of-funds and direct investment model, covering stages from angel to Pre-IPO. Sectors such as AI, big data, SaaS, innovative drugs, and medical devices are targeted. Offices are maintained in Hong Kong, Beijing, Shanghai, Shenzhen, and Silicon Valley. Strategic partnerships with high-performing funds are established to build a collaborative investment ecosystem. The goal is set to manage over 10 billion USD in assets with a professional team spanning China and the US.
Banyan Pacific Capital offers Technology Investments and Life Sciences Investments.